Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care
- PMID: 24428591
- PMCID: PMC4093932
- DOI: 10.1111/bcp.12292
Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care
Abstract
Aims: Prescribing multiple medications is associated with various adverse outcomes, and polypharmacy is commonly considered suggestive of poor prescribing. Polypharmacy might thus be associated with unplanned hospitalization. We sought to test this assumption.
Methods: Scottish primary care data for 180 815 adults with long-term clinical conditions and numbers of regular medications were linked to national hospital admissions data for the following year. Using logistic regression (age, gender and deprivation adjusted), we modelled the association of prescribing with unplanned admission for patients with different numbers of long-term conditions.
Results: Admissions were more common in patients on multiple medications, but admission risk varied with the number of conditions. For patients with one condition, the odds ratio for unplanned admission for four to six medications was 1.25 (95% confidence interval 1.11-1.42) vs. one to three medications, and 3.42 (95% confidence interval 2.72-4.28) for ≥10 medications vs. one to three medications. However, this effect was greatly reduced for patients with multiple conditions; amongst patients with six or more conditions, those on four to six medications were no more likely to have unplanned admissions than those taking one to three medications (odds ratio 1.00; 95% confidence interval 0.88-1.14), and those taking ≥10 medications had a modestly increased risk of admission (odds ratio 1.50; 95% confidence interval 1.31-1.71).
Conclusions: Unplanned hospitalization is strongly associated with the number of regular medications. However, the effect is reduced in patients with multiple conditions, in whom only the most extreme levels of polypharmacy are associated with increased admissions. Assumptions that polypharmacy is always hazardous and represents poor care should be tempered by clinical assessment of the conditions for which those drugs are being prescribed.
Keywords: hospital admission; multimorbidity; polypharmacy; primary care.
© 2014 The British Pharmacological Society.
Figures

Comment in
-
Going beyond the numbers - a call to redefine polypharmacy.Br J Clin Pharmacol. 2014 Jun;77(6):915-6. doi: 10.1111/bcp.12284. Br J Clin Pharmacol. 2014. PMID: 24853404 Free PMC article. No abstract available.
-
Assessing the harms of polypharmacy requires careful interpretation and consistent definitions.Br J Clin Pharmacol. 2014 Sep;78(3):670-1. doi: 10.1111/bcp.12359. Br J Clin Pharmacol. 2014. PMID: 25279408 Free PMC article. No abstract available.
-
Response to: assessing the harms of polypharmacy requires careful interpretation and consistent definitions.Br J Clin Pharmacol. 2014 Sep;78(3):672-3. doi: 10.1111/bcp.12358. Br J Clin Pharmacol. 2014. PMID: 25279409 Free PMC article. No abstract available.
Similar articles
-
Cardiovascular polypharmacy is not associated with unplanned hospitalisation: evidence from a retrospective cohort study.BMC Fam Pract. 2014 Mar 31;15:58. doi: 10.1186/1471-2296-15-58. BMC Fam Pract. 2014. PMID: 24684851 Free PMC article.
-
The effect of physical multimorbidity, mental health conditions and socioeconomic deprivation on unplanned admissions to hospital: a retrospective cohort study.CMAJ. 2013 Mar 19;185(5):E221-8. doi: 10.1503/cmaj.121349. Epub 2013 Feb 19. CMAJ. 2013. PMID: 23422444 Free PMC article.
-
Prevalence of polypharmacy in a Scottish primary care population.Eur J Clin Pharmacol. 2014 May;70(5):575-81. doi: 10.1007/s00228-013-1639-9. Epub 2014 Feb 1. Eur J Clin Pharmacol. 2014. PMID: 24487416
-
Polypharmacy and Unplanned Hospitalizations in Patients with Rheumatoid Arthritis.J Rheumatol. 2017 Dec;44(12):1786-1793. doi: 10.3899/jrheum.160818. Epub 2017 Oct 1. J Rheumatol. 2017. PMID: 28966210
-
Primary Care Medication Safety Surveillance with Integrated Primary and Secondary Care Electronic Health Records: A Cross-Sectional Study.Drug Saf. 2015 Jul;38(7):671-82. doi: 10.1007/s40264-015-0304-x. Drug Saf. 2015. PMID: 26100143 Free PMC article.
Cited by
-
An overview of prevalence, determinants and health outcomes of polypharmacy.Ther Adv Drug Saf. 2020 Jun 12;11:2042098620933741. doi: 10.1177/2042098620933741. eCollection 2020. Ther Adv Drug Saf. 2020. PMID: 32587680 Free PMC article. Review.
-
The Association Between Medication Use in Older Women with Early-Stage Operable Primary Breast Cancer and Decision Regarding Primary Treatment.Oncologist. 2023 Mar 17;28(3):e128-e135. doi: 10.1093/oncolo/oyac278. Oncologist. 2023. PMID: 36718086 Free PMC article.
-
Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls.Clin Kidney J. 2021 Jul 6;14(12):2497-2523. doi: 10.1093/ckj/sfab120. eCollection 2021 Dec. Clin Kidney J. 2021. PMID: 34950462 Free PMC article.
-
Effect of a patient-centered drug review on polypharmacy in primary care patients: study protocol for a cluster-randomized controlled trial.Trials. 2015 Aug 26;16:380. doi: 10.1186/s13063-015-0915-7. Trials. 2015. PMID: 26306691 Free PMC article. Clinical Trial.
-
Identification of Potentially Inappropriate Medications in Frail Older Adults Residing in Long-Term Care: A Retrospective Chart Review Study.Drugs Real World Outcomes. 2023 Mar;10(1):97-106. doi: 10.1007/s40801-022-00342-2. Epub 2022 Nov 27. Drugs Real World Outcomes. 2023. PMID: 36436174 Free PMC article.
References
-
- Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54:1516–1523. - PubMed
-
- Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37–43. - PubMed
-
- Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716–724. - PubMed
-
- Guthrie B, McCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ. 2011;342:d3514. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources